Nanologica AB (publ) (FRA:4YD)

Germany flag Germany · Delayed Price · Currency is EUR
0.0038
+0.0016 (72.73%)
At close: Mar 27, 2026
Market Cap3.53M -73.4%
Revenue (ttm)1.95M +45.3%
Net Income-4.74M
EPS-0.05
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume7
Open0.0038
Previous Close0.0022
Day's Range0.0038 - 0.0038
52-Week Range0.0022 - 0.1475
Betan/a
RSI25.13
Earnings DateApr 24, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Employees 19
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4YD

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial numbers in SEK Financial Statements